PPARG and infarction: Retinoid X receptor (RXR)/PPARγ agonists, including bexarotene and rosiglitazone, elevated the number of Ym1 positive neutrophils by inhibiting NF-κB transactivation, which was also associated with the attenuation of BBB leakage, infarction enlargement, and neurological deficits (73, 218).